TELEMUS CAPITAL, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,045 filers reported holding BAXTER INTL INC in Q4 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
TELEMUS CAPITAL, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$301,543
-56.3%
7,990
-47.3%
0.03%
-51.7%
Q2 2023$690,690
+9.4%
15,160
-2.6%
0.06%
+3.6%
Q1 2023$631,438
-19.8%
15,568
-4.2%
0.06%
-22.2%
Q4 2022$787,555
-12.9%
16,255
-3.2%
0.07%
-22.6%
Q3 2022$904,000
-18.0%
16,785
-2.2%
0.09%
-13.1%
Q2 2022$1,102,000
-25.8%
17,161
-10.4%
0.11%
-17.7%
Q1 2022$1,486,000
-13.8%
19,163
-4.5%
0.13%
-6.5%
Q4 2021$1,723,000
+5.8%
20,069
-0.8%
0.14%
+0.7%
Q3 2021$1,628,000
+44.7%
20,241
+44.8%
0.14%
+70.4%
Q2 2021$1,125,000
-5.6%
13,981
-0.0%
0.08%
-1.2%
Q1 2021$1,192,000
+11.2%
13,983
+4.6%
0.08%
+2.5%
Q4 2020$1,072,000
+2.3%
13,362
+4.4%
0.08%
+3.9%
Q3 2020$1,048,000
+1.1%
12,803
+5.3%
0.08%
-6.1%
Q2 2020$1,037,000
-6.7%
12,164
-1.5%
0.08%
-9.9%
Q1 2020$1,112,000
+4.6%
12,349
-2.9%
0.09%
+11.0%
Q4 2019$1,063,000
-5.5%
12,715
-1.1%
0.08%
-8.9%
Q3 2019$1,125,000
+4.1%
12,858
-2.6%
0.09%
-6.2%
Q2 2019$1,081,000
+0.6%
13,198
-0.2%
0.10%
+17.1%
Q1 2019$1,075,000
+22.2%
13,218
-1.1%
0.08%
+15.5%
Q4 2018$880,000
-52.0%
13,369
-43.8%
0.07%
-48.2%
Q3 2018$1,833,000
+1.7%
23,774
-2.7%
0.14%
-1.4%
Q2 2018$1,803,000
+99.4%
24,422
+75.7%
0.14%
+93.1%
Q1 2018$904,000
-2.3%
13,899
-2.9%
0.07%0.0%
Q4 2017$925,00014,3170.07%
Other shareholders
BAXTER INTL INC shareholders Q4 2017
NameSharesValueWeighting ↓
Third Point 36,000,000$2,658,240,00018.52%
SECTOR GAMMA AS 721,058$53,243,0008.85%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,747,061$202,843,0005.38%
Veritas Asset Management LLP 8,852,005$653,632,0005.36%
Knowledge Leaders Capital, LLC 79,384$5,862,0004.39%
HealthCor Management, L.P. 1,800,000$132,912,0004.22%
Progressive Investment Management Corp 79,282$5,854,0003.78%
13D Management LLC 200,318$14,791,0003.77%
ARGENT CAPITAL MANAGEMENT LLC 1,288,236$95,123,0003.42%
Chiron Investment Management, LLC 612,787$45,248,0003.12%
View complete list of BAXTER INTL INC shareholders